Related Experiment Video

Updated: Jul 1, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk

Luciano Consuegra-Sanchez1, Salim Fredericks, Juan Carlos Kaski

  • 1Cardiovascular Biology Research Centre, St. George's, University of London, Cranmer Terrace, UK.

Atherosclerosis
|September 16, 2008
PubMed

Insights

Pregnancy-associated plasma protein-A (PAPP-A) shows promise as a cardiovascular risk marker, indicating plaque instability and disease extent. Further research is needed to address limitations for clinical use.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Discovery
  • Clinical Risk Prediction

Background:

  • Cardiovascular events remain a leading cause of mortality.
  • Accurate risk stratification is crucial for effective patient management.
  • Novel biomarkers are needed to enhance prediction of cardiovascular events.

Purpose of the Study:

  • To review the evidence for pregnancy-associated plasma protein-A (PAPP-A) as a cardiovascular risk marker.
  • To discuss the potential role of PAPP-A in atherosclerosis and plaque instability.
  • To explore limitations hindering the clinical application of PAPP-A.

Main Methods:

  • Literature review of current evidence on PAPP-A and cardiovascular risk.
  • Analysis of PAPP-A's role in atherosclerotic lesion development.
  • Discussion of PAPP-A's utility in acute and stable coronary disease.

Main Results:

  • PAPP-A is implicated in the development and instability of atherosclerotic plaques.
  • Elevated PAPP-A levels correlate with adverse outcomes in cardiovascular disease patients.
  • PAPP-A demonstrates potential as a marker for cardiovascular disease extent.

Conclusions:

  • PAPP-A is a promising biomarker for cardiovascular risk assessment.
  • Its role in plaque instability and disease progression warrants further investigation.
  • Clinical implementation requires addressing current limitations and standardization.

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...